High Dose Ifosfamide as a 2nd or 3rd Line Chemotherapy

[Elodie_Espesset]

Another publication that found synovial sarcoma particularly sensitive to high dose ifosfamide:

http://www.ncbi.nlm.nih.gov/pubmed/21734417